Publication Detail
The publication detail shows the title, authors (with indicators showing other profiled authors), information on the publishing organization, abstract and a link to the article in PubMed. This abstract is what is used to create the fingerprint of the publication. If any grants are referenced by the publication, they will be listed here as well.
Glycomic analysis of human mast cells, eosinophils and basophils.
Simon J North; Stephan von Gunten; Aristotelis Antonopoulos; Alana Trollope; Donald W MacGlashan; Jihye Jang-Lee; Anne Dell; Dean D Metcalfe; Arnold S Kirshenbaum; Bruce S Bochner; et al. (Profiled Authors: Donald Macglashan; Arnold Kirshenbaum; Bruce Bochner)
Division of Molecular Biosciences, Faculty of Natural Sciences, Imperial College London, London SW7 2AZ, UK.
Glycobiology 2012;22(1):12-22.
In allergic diseases such as asthma, eosinophils, basophils and mast cells, through release of preformed and newly generated mediators, granule proteins and cytokines, are recognized as key effector cells. While their surface protein phenotypes, mediator release profiles, ontogeny, cell trafficking and genomes have been generally explored and compared, there has yet to be any thorough analysis and comparison of their glycomes. Such studies are critical to understand the contribution of carbohydrates to the induction and regulation of allergic inflammatory responses and are now possible using improved technologies for detecting and characterizing cell-derived glycans. We thus report here the application of high-sensitivity mass spectrometric-based glycomics methodologies to the analysis of N-linked glycans derived from isolated populations of human mast cells, eosinophils and basophils. The samples were subjected to matrix-assisted laser desorption ionization (MALDI) time-of-flight (TOF) screening analyses and MALDI-TOF/TOF sequencing studies. Results reveal substantive quantities of terminal N-acetylglucosamine containing structures in both the eosinophil and the basophil samples, whereas mast cells display greater relative quantities of sialylated terminal epitopes. For the first time, we characterize the cell surface glycan structures of principal allergic effector cells, which by interaction with glycan-binding proteins (e.g. lectins) have the possibility to dictate cellular functions, and might thus have important implications for the pathogenesis of inflammatory and allergic diseases.
Scientific Context
This section shows information related to the publication - computed using the fingerprint of the publication - including related publications, related experts and related grants with fingerprints representing significant amounts of overlap between their fingerprint and this publication. The red dots indicate whether those experts or terms appear within the publication, thereby showing potential and actual connections.
Related Publications
-
1.
2000K K Kikly; B S Bochner; S D Freeman; K B Tan; K T Gallagher; K J D'alessio; S D Holmes; J A Abrahamson; C L Erickson-Miller; P R Murdock; et al.
Identification of SAF-2, a novel siglec expressed on eosinophils, mast cells, and basophils.
The Journal of allergy and clinical immunology 2000;105(6 Pt 1):1093-100. -
2.
2003Christopher E Von Seggern; Paul E Zarek; Robert J Cotter
Analytical chemistry 2003;75(23):6523-30. -
3.
2005Bruce S Bochner; Richard A Alvarez; Padmaja Mehta; Nicolai V Bovin; Ola Blixt; John R White; Ronald L Schnaar
Glycan array screening reveals a candidate ligand for Siglec-8.
The Journal of biological chemistry 2005;280(6):4307-12.
Related Topics
Appears in this Publication
Related Experts
Author of this Publication
-
Internal ExpertsPublications
-
176









-
206









-
35









-
183









-
209









-
329










